Innovation in Healthcare & Biomedical Research
Date/Time: Friday, March 5th - 12pm to 1pm MST / 2pm to 3pm EST About: Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services (HHS) to form a joint initiative called BLUE KNIGHT™ to support innovation in mutual areas of interest. Blue Knight is dedicated to anticipating potential health security threats, activating the global innovation community, and amplifying scientific and technological advancements with the aim to prepare for and respond to our rapidly evolving global health environment. The initiative aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases. Join this informative session hosted by the Pandemic Impact Fund with Rachel Rath, the Director of the BARDA Alliance for Johnson & Johnson Innovation - JLABS, based at JLABS @ Washington, DC. Johnson & Johnson Innovation – JLABS (JLABS) is the incubator arm of the Johnson & Johnson Family of Companies and part of Johnson & Johnson Innovation, a global network designed to support and harness innovation happening outside of the Johnson & Johnson Family of Companies. Rachel manages the collaboration between JLABS and BARDA, providing strategic direction, alliance management, and oversight of all operational activities, including managing the sourcing and selection of high potential companies for JLABS locations and leading a cross-departmental team to develop global educational programming. Who Should Attend: Entrepreneurs, investors, service providers; anyone interested in learning more about the Blue Knight program and about applying for JLABS and Blue Knight.
Date/Time: Friday, March 5th - 12pm to 1pm MST / 2pm to 3pm EST
About: Johnson & Johnson Innovation – JLABS is collaborating with the Biomedical Advanced Research and Development Authority (BARDA), a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services (HHS) to form a joint initiative called BLUE KNIGHT™ to support innovation in mutual areas of interest. Blue Knight is dedicated to anticipating potential health security threats, activating the global innovation community, and amplifying scientific and technological advancements with the aim to prepare for and respond to our rapidly evolving global health environment. The initiative aims to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases.
Join this informative session hosted by the Pandemic Impact Fund with Rachel Rath, the Director of the BARDA Alliance for Johnson & Johnson Innovation - JLABS, based at JLABS @ Washington, DC. Johnson & Johnson Innovation – JLABS (JLABS) is the incubator arm of the Johnson & Johnson Family of Companies and part of Johnson & Johnson Innovation, a global network designed to support and harness innovation happening outside of the Johnson & Johnson Family of Companies. Rachel manages the collaboration between JLABS and BARDA, providing strategic direction, alliance management, and oversight of all operational activities, including managing the sourcing and selection of high potential companies for JLABS locations and leading a cross-departmental team to develop global educational programming.
Who Should Attend: Entrepreneurs, investors, service providers; anyone interested in learning more about the Blue Knight program and about applying for JLABS and Blue Knight.
This is a FREE 1 hour, interactive webinar open to anyone interested in learning more about angel investing and VC.